Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study

Figure 1

Flow diagram of patients with rheumatoid arthritis treated with adalimumab and methotrexate, and then discontinued ADA after fulfilling the pre-specified conditions. ADA, adalimumab; HONOR, Humira discontinuation withOut functional and radiographic damage progressioN follOwing sustained Remission; REM, remission.

Back to article page